General population screening for childhood type 1 diabetes: is it time for a UK strategy?

Besser, Rachel Elizabeth Jane; Ng, Sze May; Gregory, John W; Dayan, Colin M; Randell, Tabitha; Barrett, Timothy

Besser, Rachel Elizabeth Jane; Ng, Sze May; Gregory, John W; Dayan, Colin M; Randell, Tabitha; Barrett, Timothy.

Afiliação

Besser REJ; Department of Paediatric Diabetes and Endocrinology, NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK rachel.besser@ouh.nhs.uk.
Ng SM; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Gregory JW; Paediatric Department, Southport and Ormskirk NHS Trust, Ormskirk, UK.
Dayan CM; Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
Randell T; Division of Population Health, School of Medicine, Cardiff University, Cardiff, UK.
Barrett T; Clinical Diabetes and Metabolism, Cardiff University School of Medicine, Cardiff, UK.

Arch Dis Child ; 107(9): 790-795, 2022 09.

Article em En | MEDLINE | ID: mdl-34740879

Assuntos

Diabetes Mellitus Tipo 1; Cetoacidose Diabética; Adolescente; Autoanticorpos; Criança; Diabetes Mellitus Tipo 1/diagnóstico; Diabetes Mellitus Tipo 1/epidemiologia; Diabetes Mellitus Tipo 1/genética; Cetoacidose Diabética/diagnóstico; Humanos; Programas de Rastreamento; Reino Unido/epidemiologia

Palavras-chave

child health; endocrinology; global health

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Child / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google